The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivo.

by Xiaoyang Ling, Erika Spaeth, Ye Chen, Yuexi Shi, Weiguo Zhang, Wendy Schober, Numsen Hail, Marina Konopleva, Michael Andreeff
Published 2013-01-01